文献速递新发突发、热带与寄生虫病细菌感染、耐药与抗菌药物

中性粒细胞胞外诱捕网:改善感染性疾病结局的新兴治疗靶点

Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes.
PubMed 文献 · J Infect Dis · 2024-01-01

本综述总结中性粒细胞胞外诱捕网(NETs)的当前认识,讨论NET形成加重疟疾、登革热、流感、细菌脓毒症和SARS-CoV-2感染等疾病发病与死亡的机制,并探索未来可研究的辅助治疗,包括特异性NET抑制剂及可能重定位为NET抑制剂的美国FDA已批准药物。

要点

  • NETs由组蛋白与DNA复合物及蛋白酶组成,经NETosis释放以捕获病原体。
  • 血管内NETosis可驱动大规模炎症反应,加重多种感染性疾病发病与死亡。
  • 特异性NET抑制剂及FDA已批准药物重定位为NET抑制剂是潜在辅助治疗方向。

核心结论

  • NETs是改善感染性疾病结局的新兴治疗靶点,特异性NET抑制剂及可重定位的FDA已批准药物值得未来研究。

研究设计与样本

  • 综述,总结NETs当前认识、讨论NET形成加重发病与死亡的感染性疾病,并探索未来可研究的辅助治疗。

主要发现

  • 血管内NETosis可驱动大规模炎症反应,已显示在疟疾、登革热、流感、细菌脓毒症和严重急性呼吸综合征冠状病毒2感染中加重发病与死亡。

临床怎么用

  • 作者认为特异性NET抑制剂及美国FDA已批准药物重定位为NET抑制剂可作为未来研究治疗NET病理生理驱动的严重感染的潜在辅助治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neutrophils possess a diverse repertoire of pathogen clearance mechanisms, one of which is the formation of neutrophil extracellular traps (NETs). NETs are complexes of histone proteins and DNA coated with proteolytic enzymes that are released extracellularly to entrap pathogens and aid in their clearance, in a process known as NETosis. Intravascular NETosis may drive a massive inflammatory response that has been shown to contribute to morbidity and mortality in many infectious diseases, including malaria, dengue fever, influenza, bacterial sepsis, and severe acute respiratory syndrome coronavirus 2 infection. In this review we seek to (1) summarize the current understanding of NETs, (2) discuss infectious diseases in which NET formation contributes to morbidity and mortality, and (3) explore potential adjunctive therapeutics that may be considered for future study in treating severe infections driven by NET pathophysiology. This includes drugs specifically targeting NET inhibition and US Food and Drug Administration-approved drugs that may be repurposed as NET inhibitors.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Meier A, Sakoulas G, Nizet V, et al. Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes. J Infect Dis. 2024. PMID: 38728418. doi:10.1093/infdis/jiae252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。